Rodney Young
2023 - RAPT Therapeutics
In 2023, Rodney Young earned a total compensation of $2.2M as Chief Financial Officer at RAPT Therapeutics, a 41% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $149,000 |
|---|---|
| Option Awards | $1,558,662 |
| Salary | $459,000 |
| Other | $8,564 |
| Total | $2,175,226 |
Young received $1.6M in option awards, accounting for 72% of the total pay in 2023.
Young also received $149K in non-equity incentive plan, $459K in salary and $8.6K in other compensation.
Rankings
In 2023, Rodney Young's compensation ranked 467th out of 2,816 executives tracked by ExecPay. In other words, Young earned more than 83.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 467 out of 2,816 | 83rd |
Division Manufacturing | 269 out of 1,551 | 83rd |
Major group Chemicals And Allied Products | 187 out of 877 | 79th |
Industry group Drugs | 184 out of 840 | 78th |
Industry Pharmaceutical Preparations | 115 out of 605 | 81st |
Source: SEC filing on April 5, 2024.
Young's colleagues
We found two more compensation records of executives who worked with Rodney Young at RAPT Therapeutics in 2023.